Correction to: Different Doses of Sacubitril/Valsartan Compared with Olmesartan in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis

被引：0
作者：
Amjaad Ibrahim Almarjan
Sara Abdulaziz Almarjan
Ahmed Taher Masoud
机构：
[1] Prince Mohammed bin Abdulaziz Hospital,Department of Internal Medicine
[2] Al Kharj Military Hospitals,Department of Pharmaceutical Services
[3] Fayoum University,Faculty of Medicine
来源：
High Blood Pressure & Cardiovascular Prevention | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：385 / 385
相关论文
共 50 条
[31]   The efficacy and safety of sacubitril/valsartan in chronic kidney disease: a systematic review and meta-analysis [J].
Wei Zhou ;
Xinyue Yang ;
JingJing Jin ;
Meijuan Cheng ;
Yajing Li ;
Yaling Bai ;
Jinsheng Xu .
International Urology and Nephrology, 2024, 56 :181-190
[32]   The Efficacy and Safety of Sacubitril/Valsartan Compared to Valsartan in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fractions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J].
Kommu, Sharath ;
Berg, Richard L. .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (06)
[33]   Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double-blind, 8-week study [J].
Huo, Yong ;
Li, Weimin ;
Webb, Randy ;
Zhao, Li ;
Wang, Qian ;
Guo, Weinong .
JOURNAL OF CLINICAL HYPERTENSION, 2019, 21 (01) :67-76
[34]   Sacubitril/valsartan and arrhythmic burden in patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis [J].
Pozzi, A. ;
Abete, R. ;
Tavano, E. ;
Kristensen, S. L. ;
Rea, F. ;
Iorio, A. ;
Iacovoni, A. ;
Corrado, G. ;
Wong, C. .
HEART FAILURE REVIEWS, 2023, 28 (06) :1395-1403
[35]   RETRACTED: Effects and Safety of Sacubitril/Valsartan for Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis (Retracted Article) [J].
Liu, Lang ;
Ding, Xiaofang ;
Han, Yaxiang ;
Lv, Jianfeng .
JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
[36]   Efficacy and safety of low-dose sacubitril/valsartan in heart failure patients: A systematic review and meta-analysis [J].
Chen, Wen-Wen ;
Jiang, Juan ;
Gao, Jie ;
Zhang, Xiu-Zhen ;
Li, Yuan-Min ;
Liu, Yan-Lin ;
Dang, He-Qin .
CLINICAL CARDIOLOGY, 2023, 46 (03) :296-303
[37]   Sacubitril/valsartan and arrhythmic burden in patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis [J].
A. Pozzi ;
R. Abete ;
E. Tavano ;
S. L. Kristensen ;
F. Rea ;
A. Iorio ;
A. Iacovoni ;
G. Corrado ;
C. Wong .
Heart Failure Reviews, 2023, 28 :1395-1403
[38]   Efficacy and safety of sacubitril/valsartan in the treatment of middle-aged and elderly patients with hypertension: a systematic review and meta-analysis of randomized controlled trials [J].
Wu, Hong-Xing ;
Liu, Ke-Ke ;
Li, Bo-Ning ;
Liu, Sha ;
Jin, Jing-Chun .
ANNALS OF PALLIATIVE MEDICINE, 2022, :1811-1825
[39]   Antihypertensive effect of azilsartan versus olmesartan in patients with essential hypertension: a meta-analysis [J].
Zhao, Di ;
Liu, Hui ;
Dong, Pingshuan .
IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 (02) :481-488
[40]   Antihypertensive effect of azilsartan versus olmesartan in patients with essential hypertension: a meta-analysis [J].
Di Zhao ;
Hui Liu ;
Pingshuan Dong .
Irish Journal of Medical Science (1971 -), 2019, 188 :481-488
12345